Delivery Order SPE2DB24D8003-SPE2DB24FJTKD
Award Date
8/22/24
Potential Completion Date
8/23/24
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of fluticasone propionate HFA 110 mcg 12 gm inhalers. The contract has a ceiling value of $1,421.88 and a performance period through April 3, 2025. This award is part of Dakota Drug, Inc.'s existing Indefinite Delivery Contract (IDC) SPE2DB24D8001 with the DLA Troop Support Medical division, which is valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the delivery of fluticasone propionate HFA 220 mcg 12 g inhalers, with a ceiling value of $2,331.29 and a period of performance through August 28, 2024. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of fluticasone propionate HFA 110 mcg 12 gm inhalers. The firm-fixed-price contract has a ceiling value of $3,943.64 and a performance period extending through January 24, 2025. Dakota Drug, Inc. is the prime contractor, and there are no major subcontractors noted. This award is part of the DLA Troop Support Medical's ECAT Generation V...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $2,379.65 firm-fixed-price delivery order is for the provision of fluticasone propionate HFA 110 mcg 12 gm inhalers. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that allows Dakota Drug, Inc. to provide a comprehensive range of pharmaceutical...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business that specializes in providing pharmaceutical products, medical supplies, and healthcare equipment to the U.S. federal government. The contract, valued at $7,225.70, is a firm fixed-price delivery order for the supply of Fluticasone-Salmeterol 115-21 12GM inhalers. The award is associated with a larger Indefinite Delivery Contract (IDC) between Dakota...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. The contract has a firm fixed price of $3,085.17 and a period of performance through January 31, 2024. The contract is not set-aside and is part of the DLA Troop Support Medical's ECAT Generation V Program, a large Indefinite Delivery Contract (IDC) with a ceiling value...
This is a federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is a delivery order with a ceiling value of $1,184.90 and a firm fixed price pricing type. It was awarded by the Defense Logistics Agency (DLA), a defense agency, on June 26, 2025, with a completion date of June 27, 2025. The contract is for the supply of FLUTICASONE PROP HFA 110 MCG 12GM, a pharmaceutical product. This award is not associated with a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, with a ceiling value of $3,695.85, is for the delivery of Fluticasone Prop HFA 220 MCG 12GM pharmaceutical products. The contract is a Firm Fixed Price type and does not have a set-aside designation. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at...
This federal contract award, valued at $1,185.11, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a prescription medication used to treat asthma and COPD. The contract has a firm fixed price structure and an ultimate completion date of August 16, 2024. This award is associated with a larger Indefinite...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $4,830.16, is for the delivery of fluticasone-salmeterol 230-21 12GM pharmaceutical products to support U.S. Armed Forces medical operations. The contract is part of the DLA Troop Support Medical's ECAT Generation V Program, a larger indefinite delivery contract (IDC) vehicle with a ceiling value of...